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Abstract: The aim of this clinical study was to investigate the effects of oxytocin and cloprostenol application via
umbilical artery on the time and rate of fetal membrane removal in cows with dystocia immediately after parturition.
Metabolic profiles indicated certain serum biochemical parameters that were also determined in the cows. The study
was performed on 60 cows with dystocia. All of the cows were randomly divided into 3 equal subgroups. The first group
was injected with 100 IU oxytocin, while the second group was treated with 0.15 mg cloprostenol and the third group
(the control group) received 10 mL 0.9% NaCl via intraumbilical artery. Blood samples were randomly taken from
the jugular veins of 10 cows from each group. No significant differences were determined between the groups with
regard to the values of aspartate aminotransferase, alkaline phosphatase, creatine kinase, total protein and bilirubin,
albumin, glucose, Ca, Na, or K (P > 0.05). The lactate dehydrogenase level in the oxytocin group was determined to be
significantly lower when compared to the cloprostenol and control groups (P < 0.05). The value of gamma-glutamyl
transferase in the oxytocin group was significantly higher than in the other groups (P < 0.05). The time and rate of fetal
membrane removal were not different among the groups (P > 0.05). In conclusion, the administration of combinations
of other uterotonics and enzymes together with these agents should be investigated to determine the effects on cows
with retained placenta prophylaxis. Future applications may also study the effects of these agents on fertility and time
and rate of fetal membrane removal in cows with normal parturition and dystocia at the herd level.
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İneklerde güç doğum sonrası göbek kordonu arteri yoluyla oksitosin ve
kloprestenol uygulamasının yavru zarlarının atılım süresi ve oranı üzerine etkisi
Özet: Bu çalışmanın amacı, güç doğumdan hemen sonra ineklere göbek kordonu arteri yoluyla verilen oksitosin ve
kloprestenol’un, yavru zarlarının atılımı oranı ve süresi üzerine etkilerini araştırmaktı. İneklerin bazı biokimyasal
parametreleri de tespit edilerek, metabolik profilleri ortaya kondu. Çalışmada, güç doğum yapmış 60 adet inek kullanıldı.
Tüm inekler, rastgele 3 eşit gruba ayrıldı. Birinci gruba 100 IU oksitosin, ikinci gruba 0,15 mg kloprestenol ve üçüncü
gruba (kontrol) ise 10 mL % 0,9 NaCl göbek kordonu arteri yoluyla verildi. Her bir gruptaki rastgele 10’ar inekten, vena
* E-mail: yakar@cumhuriyet.edu.tr
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jugularisten kan alındı. Gruplar arasında, AST, ALP, CK, total protein, total billirubin, albumin, glükoz, Ca, Na ve K
değerleri yönüyle önemli bir farklılık (P > 0,05) yoktu. Oksitosin grubundaki LDH seviyesi, kloprestenol ve kontrol
grubuna göre önemli oranda daha düşük (P < 0,05) tespit edildi. Diğer 2 gruba göre, oksitosin grubunda GGT miktarı
önemli oranda yüksek (P < 0,05) bulundu. Gruplar arası, yavru zarlarının atılım süresi ve oranı yönünden farklılık
yoktu. Sonuç olarak, bu maddeler ile birlikte diğer uterotonik ve enzim kombinasyonlarının kullanımının, ineklerin
retensiyo sekundinarum profilaksisindeki etkileri araştırılmalıdır. Bu uygulamaların, gelecekte sürü seviyesinde normal
ve güç doğumlu ineklerde yavru zarlarının atılım süresi ve oranı ile fertilite üzerine etkileri de çalışılabilirdi.
Anahtar sözcükler: Kloprostenol, inek, güç doğum, yavru zarları, oksitosin, göbek kordonu

Introduction
Fetal membranes are normally expelled within 3 to 8
h after parturition and their retention for more than
12 to 24 h is considered retained placenta (RP). The
incidence of RP in cows ranges from 2% to 60%, with
an average of approximately 10%. Dystocia increases
the percentage of cows affected by RP. The economic
impact of RP is reflected in loss of milk, impaired
fertility, and a high culling rate. The consequences
of RP are an increase in the calving to first service
interval, a reduction in the pregnancy rate to first
service, an increase in the number of services per
conception, and a longer calving interval (1-3).
The physiological delivery of the placenta after
parturition requires adequate and regular uterine
contractions. A deficiency in secretions of PGF2α,
oxytocin, or serum Ca concentration, which
maintain adequate contraction of the uterus, may
cause RP, increase the risk of dystocia, and delay the
involution of the uterus (4,5). High concentrations of
PGF2α and PGE2 are produced by the uterus during
the early postpartum period in cows and may play
an important role in both placental separation and
uterine involution (6). Many factors have been
implicated in the production of RP and many of
these are interrelated, such as uterine atony, abortion,
delayed gestation, dystocia, high environmental
temperatures, early parturition, infections, twin
pregnancy, and vitamin and mineral deficiencies
(1,4,7).
For the treatment and prevention of RP, injections
of ecbolic drugs and enzymes such as oxytocin,
prostaglandin, collagenase, and hyaluronidase have
been administered within 24 h of parturition (2,3,811). Many investigators (8,9,12-14) have shown
collagenase application via umbilical artery after
parturition to reduce the time and increase the rate
of fetal membrane removal in cows.
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If RP is left untreated in women, there is high
risk of maternal death. However, manual removal
of the placenta is an invasive procedure with its own
serious complications of hemorrhage, infection, or
genital tract trauma (15). Therefore, the injection of
oxytocin, ergometrine, or PGF2α via the intraumbilical
vein has been suggested as an alternative treatment
for women experiencing RP. The method relies on
the injected solution passing down the umbilical
cord and through the placental bed to contract the
myometrium behind the placenta, thereby causing its
detachment (15-19).
Some investigators (15-18,20,21) suggest that
intraumbilical vein injections of oxytocin or PGF2α
may be a beneficial, cheap, nonaggressive, nonsurgical
method for treating RP in women. Others (22,23)
indicate that intraumbilical vein injections of
oxytocin are not effective for the removal of RP.
Kudlac et al. (24) investigated biochemical
parameters in cows with and without RP and found
that the values of these parameters (total protein, Ca,
alkaline phosphatase (ALP), and gamma-glutamyl
transferase (GGT)) mostly ranged within the interval
of reference values. On the other hand, the cows with
RP had significantly lower concentrations of glucose
and higher bilirubin, aspartate aminotransferase
(AST), and lactate dehydrogenase (LDH). Castillo
et al. (25) evaluated some biochemical parameters
(glucose, total protein, albumin, AST, and ALP) in
cows after and before parturition with no significant
differences.
In this study, a new application of oxytocin
and cloprostenol in cows with dystocia via
the intraumbilical artery was employed. Some
biochemical parameters were also investigated,
as were the effects of oxytocin and cloprostenol
application via umbilical artery on the time and rate
of fetal membrane removal in cows with dystocia.
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Materials and methods
Hormonal drugs
Oxytocin (Vetaş Oksitosin, 10 IU/mL) and
d-cloprostenol (Dalmazin Enj., 0.075 mg/mL) were
purchased from Vetaş (İstanbul, Turkey).
Animals and location
The study was performed on 60 cows of differing
breeds and ages (2-9 years) that had been brought to
the Clinic of Obstetrics and Gynecology in the Faculty
of Veterinary Medicine at Fırat University. The study
was carried out in Elazığ between 1 October and 30
December 2009.
Treatment schedule
All of the cows had dystocia and single-calf
parturition. The cows were randomly divided into 3
equal subgroups. The first, second, and third groups
(each group containing 20 cows) were administered
100 IU oxytocin, 0.15 mg d-cloprostenol, and 10
mL 0.9% NaCl, respectively, via intraumbilical
artery immediately after expulsion of the fetus. All
injections were applied to the umbilical cords, whose
arteries and veins were massaged for 5 min for blood
remnant removal. The injection to the umbilical
cord artery was carried out as near as possible to
the uterus using a spinal needle (22 G, 0.70 × 89
mm, Exelint International Co., Los Angeles, CA,
USA). Additionally, in order to better introduce
the injected substances (oxytocin, cloprostenol, or
NaCl) to the uterus, the upward umbilical artery was
massaged upwardly after each application and then
the umbilical artery was clamped (Figures 1-4). All of
the cows were observed at intervals of 10 min/h after
parturition to determine the time of fetal membrane

Figure 1. The spinal needle and umbilical artery used in this
study.

removal. No fetal membrane removal within 24 h of
parturition was defined as RP.
Blood sample
measurements

collection

and

biochemical

Blood samples (10 mL) were obtained at random
by vein puncture from the jugular veins of 10 cows
from each group immediately after parturition and
before the intraumbilical artery injections. Serum
was separated by centrifugation and stored at −20 °C
until analysis. Concentrations of serum biochemical
parameters including ALP, AST, GGT, LDH, creatine
kinase (CK), total protein, albumin, glucose,
total bilirubin, calcium, sodium, and potassium
were analyzed with a clinical chemistry analyzer
(ADVIA 1200 Chemistry System, Bayer-Healthcare,
Leverkusen, Germany).
Statistical analysis
All biochemical parameters and fetal membrane
removal times were evaluated with Kruskal-Wallis
variance analyses and the independent Student’s
t-test. Fetal membrane removal and nonremoval
rates were evaluated by the chi-square test (26,27).

Figure 2. Injection of the tested drugs into the umbilical artery.

Figure 3. The clamped umbilical artery.
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control groups (P < 0.05). The value of GGT was
significantly higher in the oxytocin group when
compared to the other groups (P < 0.05).
Discussion
The occurrence of RP should be prevented as much as
possible (1,4,8,12), or the treatment and prevention
of RP with injections of ecbolic drugs and enzymes
such as oxytocin, prostaglandin, collagenase, and
hyaluronidase within 24 h after parturition must
be applied (2,3,8-13). The rationale for their use is
that they stimulate uterine concentrations and thus
physically aid the expulsion of the membranes (11).

Figure 4. Diagram representing the injections used in the
present study.

Results
The rates of fetal membrane removal and nonremoval
and the time of fetal membrane removal between the
groups were not different (Table 1).
Biochemical parameters of all of the cows are
given in Table 2, which shows that the values of
AST, ALP, CK, total protein, total bilirubin, albumin,
glucose, Ca, Na, and K were not significantly different
between the 3 groups. However, the level of LDH in
the oxytocin group was determined to be significantly
lower than that observed in the cloprostenol and

Mollo et al. (2) showed that the intramuscular
administration of 30 IU oxytocin immediately
after delivery and again 2-4 h later reduced the
incidence of RP significantly in Holstein cows and
consequently reduced the occurrence of endometritis
post-RP. Oxytocin treatment also improved the
herd reproductive performance by shortening the
average interval from calving to conception. Stocker
and Waelchli (3) reported that intramuscular
administration of 25 mg dinoprost immediately after
parturition reduced the incidence of RP significantly
in cows with dystocia. Miller and Lodge (10) reported
no significant difference in the rate of RP in the cows
treated intramuscularly with 100 IU oxytocin 3-6
h after calving. Haffner et al. (28) concluded that
umbilical artery injections of collagenase were a safe
and potentially effective treatment for RP in mares.
Women given an intraumbilical injection of 20 IU
oxytocin had a significant increase in spontaneous
expulsion of the placenta within 45 min of delivery
and experienced fewer manual removals of the
placenta compared with women without treatment

Table 1. The rate and time of fetal membrane removal in the 3 groups.
Oxytocin

Cloprostenol

Control

FMR %

70% (n: 14)

55% (n: 11)

60% (n: 12)

FMNR %

30% (n: 6)

45% (n: 9)

40% (n: 8)

mean ± std. error

mean ± std. error

mean ± std. error

5.20 ± 0.39 (n: 14)

4.49 ± 0.43 (n: 11)

6.02 ± 0.56 (n: 12)

FMRT (h)

FMR: fetal membrane removal; FMNR: fetal membrane nonremoval; FMRT: fetal membrane removal time.

278

Y. AKAR, Ö. KIZIL, N. SAAT, M. YÜKSEL

Table 2. Values recorded for various parameters in the 3 groups.

Parameters

Oxytocin
mean ± std. error

Cloprostenol
mean ± std. error

Control
mean ± std. error

AST (U/L)

109.0 ± 6.9

100.7 ± 3.4

90.4 ± 2.5

ALP (U/L)

129.9 ± 6.1

120.9 ± 5.3

115.9 ± 4.9

LDH (U/L)

797.4 ± 23.7a

848.2 ± 45.5ab

910.1 ± 24.3b

GGT (U/L)

9.5 ± 0.4b

7.4 ± 0.4a

8.4 ± 0.6ab

CK (U/L)

96.5 ± 5.1

92.4 ± 4.1

91.8 ± 3.0

Total protein (g/dl)

6.92 ± 0.04

6.93 ± 0.04

7.03 ± 0.06

Albumin (g/dl)

3.08±0.02

3.12±0.02

3.05±0.04

Glucose (mg/dl)

62.2±1.8

64.6±1.2

65.9±1.4

Tbilirubin (mg/dl)

0.71±0.06

0.70±0.05

0.67±0.08

CA (mg/dl)

8.53±0.13

8.82±0.06

9.03±0.17

NA (mEq/L)

143.5±1.3

141.8±1.7

141.8±1.4

K (mEq/L)

4.5±0.1

4.4±0.1

4.6±0.1

a,b

: Different letters on the same line indicate significance (P < 0.05).

(20). Bider et al. (16) reported that intraumbilical
vein injection of 20 mg PGF2α might be a beneficial
method for treating RP. Although oxytocin and
prostaglandin administration via intraumbilical
artery, applied to cows with dystocia for the first
time in this study, appeared to have a positive effect
on the time and rate of removal of fetal membranes,
this difference was not statistically significant when
compared with the control group.
The blood serum parameters in cows from
parturition to 45 days postpartum were at almost
constant levels for AST, GGT, LDH, and bilirubin,
but were low for glucose, total protein, and Ca levels
at parturition. These parameters then increased until
20 days postpartum (29). It was observed that AST,
GGT, and CK activities were significantly increased
in the cow group with dystocia in comparison to the
cows experiencing normal parturition, whereas the
total bilirubin and glucose levels were not different
(30). The concentration of serum albumin in cows
immediately after parturition was significantly lower
in cows with RP than those without RP, although Ca
levels were not different (31). Blood serum levels of
ALP and LDH in dairy cows with and without RP
immediately after parturition were similar (32).

Doornenbal et al. (33) investigated the reference
values of blood parameters in beef cattle of different
ages and stages of lactation. Serum concentrations
of total protein and bilirubin increased with age,
as did the serum activities of AST and LDH; levels
of Ca and ALP decreased with age from birth to
10 years of age. The cows had the highest levels of
glucose at parturition, whereas levels of LDH and
AST were lower at parturition according to the
stages of lactation. The levels of AST, ALP, CK, total
protein, total bilirubin, albumin, glucose, Ca, Na,
and K determined in this study were not significantly
different among the groups. The level of LDH in the
oxytocin group was determined to be significantly
lower than in other groups (P < 0.05), but the value
of GGT in the same group was significantly higher
than in the other 2 groups (P < 0.05). The metabolic
profiles (except for LDH and GGT) between the
groups before the administrations of oxytocin and
cloprostenol were not significant, which indicates
that this parameter would have no effect on the
outcome of the treatment.
For the removal of fetal membranes from
cows after parturition, uterus contractions should
be maintained, and the role of oxytocin and
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prostaglandin at this stage is important. In this
study, the prophylactic effect of oxytocin and
prostaglandin administered via intraumbilical
artery on fetal membrane removal in cows with
dystocia was investigated. The administration of
oxytocin and prostaglandin via intraumbilical
artery in cows with dystocia was determined to

produce no significant effect on the time or rate of
fetal membrane removal. In conclusion, the study
suggests that the administration of other uterotonic
and enzyme combinations via umbilical cord should
be investigated further with regard to their effects on
reproductive performance and puerperal disorders
in cows with and without dystocia at the herd level.
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